Naveeda Riaz

Learn More
We have performed a comprehensive evaluation of single-nucleotide polymorphisms (SNPs) and haplotypes in the human TAS1R gene family, which encodes receptors for sweet and umami tastes. Complete DNA sequences of TAS1R1-, TAS1R2-, and TAS1R3-coding regions, obtained from 88 individuals of African, Asian, European, and Native American origin, revealed(More)
Stuttering is a common and sometimes severe communication disorder, of unknown primary etiology, that exists in populations worldwide. Many types of evidence suggest a genetic contribution to stuttering; however, the complex inheritance of this disorder has hindered identification of these factors. We have employed highly inbred families to increase the(More)
Homozygous mutations in GNPTAB and GNPTG are classically associated with mucolipidosis II (ML II) alpha/beta and mucolipidosis III (ML III) alpha/beta/gamma, which are rare lysosomal storage disorders characterized by multiple pathologies. Recently, variants in GNPTAB, GNPTG, and the functionally related NAGPA gene have been associated with non-syndromic(More)
The ubiquitous enzyme, dihydrofolate reductase (DHFR), is a well-studied metabolic enzyme of significant pharmacological relevance. The past research studies have shown that DHFR has emerged as an important therapeutic target for the treatment of various diseases including cancers, bacterial and protozoal infections, and the opportunistic infections that(More)
Butyrylcholinesterase present in the serum, heart, lung, intestine, liver, and kidney plays an important role in the metabolism of ester containing compounds. Several neuronal groups solely show the activity of BChE in the human brain, such as in the inhibition or the absence of AChE, BChE can replace AChE in the degradation of acetylcholine ACh. Such(More)
Microtubules have always remained a mainstay in the discussion of anti-cancer drugs. Research is being carried out since over a decade on the microtubule-binding agents. The already present drugs have acquired clinical disadvantages or limitations, most importantly, the acquired resistance. Microtubule-stabilizing anti-mitotic agents (MSAAs) has proved(More)
  • 1